WHO issues warning on deadly weed killer

A widely used farm chemical as a key ingredient in a new herbicide developed by Dow AgroSciences “possibly” causes cancer in humans, a World Health Organisation research unit has determined.

The classification of the weed killer, 2,4-dichlorophenoxyacetic acid, known as 2,4-D, was made by the WHO’s International Agency for Research on Cancer (IARC).

The IARC said it reviewed the latest scientific literature and decided to classify 2,4-D as “possibly carcinogenic to humans,” a step below the more definitive “probably carcinogenic” category but two steps above the “probably not carcinogenic” category.

SEE ALSO :Congo's militia attacks Ebola centre

IARC’s findings on 2,4-D have been awaited by environmental and consumer groups that are lobbying US regulators to tightly restrict the use of 2,4-D, as well as by farm groups and others that defend 2,4-D as an important agent in food production that does not need more restrictions.

This is not the first time this year that the organisation has linked common chemicals to cancer, which is becoming a top killer disease in Kenya. In February, the health body classified Roundup, one of the most popular weed killers in Kenya, as a possible carcinogen.

Roundup is manufactured by American seed giant Monsanto from the chemical glyphosate, which was discovered in 1970. There are more than 30 brands of glyphosate chemicals in the local market.

KEY INGREDIENT

In March, IARC said it had found another popular herbicide — glyphosate — was “probably carcinogenic to humans.” Glyphosate is the key ingredient in Monsanto Co’s Roundup herbicide and other products.

SEE ALSO :Oral health: Why we need to focus more on prevention

IARC classifications do not carry regulatory requirements but can influence regulators, lawmakers and the public. Following the glyphosate classification, some companies and government officials moved to limit glyphosate use.

Dow AgroSciences, a unit of Dow Chemical Co, has had a particular interest in IARC’s review. The company is using both glyphosate and 2,4-D in a herbicide it calls Enlist Duo that received US approval last year.

Enlist Duo is designed to be used with genetically engineered, herbicide-tolerant crops developed by Dow.

Dow had no comment on the IARC classification, but the company has said 2,4-D is a safe and valuable tool for agriculture.

IARC said it decided on the “possibly” classification because there was “inadequate evidence in humans and limited evidence in experimental animals” of ties between 2,4-D and cancer.

SEE ALSO :WHO introduces oral regimen in bid to fight TB

It said that epidemiological studies provided “strong evidence that 2,4-D induces oxidative stress ... and moderate evidence that 2,4-D causes immunosuppression ...”

However, IARC said, “epidemiological studies did not find strong or consistent increases in risk of NHL (non-Hodgkin lymphoma) or other cancers in relation to 2,4-D exposure.”

Dana Loomis, a deputy section head for IARC, said the most important studies reviewed showed mixed results, and a “sizable minority” judged the evidence as stronger than others did.

Among the research presented to IARC was an analysis funded by a Dow-backed task force that found no ties between 2,4-D and many cancers.

Some critics of 2,4-D had thought IARC would assign at least the “probably” cancer-causing classification to 2,4-D.

SEE ALSO :Court saves defaulters of medication from jail

For the latest news in entertainment check out Sde.co.ke and Pulser.co.ke , for everything sports visit Gameyetu.co.ke and ladies we have you covered on Evewoman

World Health OrganisationIARCnon-Hodgkin lymphoma